Nephrocare Health Services Limited

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has closed its trading window due to unpublished price sensitive information, including financial results for the quarter and half year ending September 30, 2026.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about the schedule of an Investor Conference to be held on September 29, 2026, at PL Capital Trident BKC, Mumbai.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about Credit Rating- Revision. India Ratings and Research Private Limited has upgraded Nephrocare Health Services Limited's bank loan facilities' long-term rating to 'IND AA-' from IND A+, with a Stable Outlook, and affirmed short-term rating to 'IND A1+'.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about Other Restructuring - Rationalisation and Consolidation of Company's Step-down Subsidiaries in the Philippines.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about Agreements with Nephrocare Health Care Services, Philippines Inc. and Renal One Dialysis Corp. for the acquisition of dialysis center assets in the Philippines for a total consideration of PhP 67,200,000 (approximately INR 10.25 crores).

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about Grant of Employee Stock Options under the NephroPlus Employee Stock Option Scheme 2026.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has acquired 100% participatory interest in Dialysis Center Almaty LLP, a Kazakhstan-based dialysis services provider, for KZT 561.66 million (approximately ₹116.35 million). The acquisition is in line with the company's strategy to expand its dialysis services network in international markets.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has received a tax demand of approximately ₹14.79 crore from the Tashkent City Tax Department, Uzbekistan, following a tax audit for the period January 1, 2023 to December 31, 2025. The company believes the demand is primarily due to a data reconciliation discrepancy and is taking steps to reconcile the underlying revenue data and evaluate legal remedies.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has announced its Q1 FY27 earnings, with revenues growing more than 20% year-on-year, driven by the strength of its platform business and disciplined execution.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about an Asset Transfer Agreement entered into by its overseas step-down wholly-owned subsidiary, Nephrocare Health Care Services, Philippines Inc., with Assumption Dialysis Center for the acquisition of identified assets related to a dialysis center in the Philippines for a total consideration of PhP 75,000,000.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on August 12, 2026, and informed the Exchange regarding voting results.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about the schedule of an investor conference to be held on 18th August, 2026, at Grand Hyatt, Mumbai.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about entering into an Asset Transfer Agreement with Juan Nephro Dialysis Center for the acquisition of identified assets relating to a dialysis center in Davao City, Philippines, for a total consideration of PhP 71,800,000.

Nephrocare Health Services Limited

Nephrocare Health Services Limited clarifies the status of its step-down subsidiary, NPHSK LLP, incorporated in Kazakhstan, stating it is a step-down subsidiary of the Company, not a step-down wholly owned subsidiary.

Nephrocare Health Services Limited

Nephrocare Health Services Limited held its 17th Annual General Meeting on August 12, 2026, through video conferencing, with 74 members in attendance. The meeting was chaired by Mr. Vikram Vuppala, Chairman and Managing Director, and the statutory auditor's report did not contain any qualifications or reservations.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about the link of the audio recording of the Investors' Conference Call held on August 12, 2026, to discuss the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per Regulation 32 of the SEBI LODR Regulations, 2015, and Regulation 41 of the SEBI ICDR Regulations, 2018. The report, issued by Crisil Ratings Limited, Monitoring Agency, provides an objective view of the utilization of the issue proceeds in relation to the objects of the Initial Public Offer (IPO).

Nephrocare Health Services Limited

Nephrocare Health Services Limited, Asia's largest dialysis network under the brand 'NephroPlus', announced its Financial Results for first quarter ended 30th June 2026, with revenue growing 23.7% YoY to ₹281.8 crore and Adjusted EBITDA growing 30.7% YoY to ₹65.1 crore.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about Investor Presentation, which includes unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.